Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Evers, Patrick ^a   Lee, Percy P ^a   DeMarco, John ^a   Agazaryan, Nzhde ^a   Sayre, James W ^b   Selch, Michael ^a   Pajonk, Frank ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STEM CELL; CONTROLLED STUDY; DNA REPAIR; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGRESSION FREE SURVIVAL; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RETROSPECTIVE STUDY; SUBVENTRICULAR ZONE; BRAIN TUMOR; FOLLOW UP; GLIOMA; MIDDLE AGED; MORTALITY; NEURAL STEM CELL; PATHOLOGY; PROGNOSIS; RADIATION DOSE; RADIATION EXPOSURE; RISK FACTOR; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; NEURAL STEM CELLS; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 77954667472     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-384     Document Type: Article

References (32)

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987-996. 10.1056/NEJMoa043330, 15758009.
2. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009, 10:459-466. 10.1016/S1470-2045(09)70025-7, 19269895.
3. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, Kornblum HI. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 2003, 100:15178-15183. 10.1073/pnas.2036535100, 299944, 14645703.
4. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63:5821-5828.
5. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401. 10.1038/nature03128, 15549107.
6. Gage FH, Coates PW, Palmer TD, Kuhn HG, Fisher LJ, Suhonen JO, Peterson DA, Suhr ST, Ray J. Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc Natl Acad Sci USA 1995, 92:11879-11883. 10.1073/pnas.92.25.11879, 40506, 8524867.
7. Goldman SA, Sim F. Neural progenitor cells of the adult brain. Novartis Found Symp 2005, 265:66-80. discussion 82-97, full_text, 16050251.
8. Reynolds BA, Tetzlaff W, Weiss S. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J Neurosci 1992, 12:4565-4574.
9. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255:1707-1710. 10.1126/science.1553558, 1553558.
10. Llaguno SA, Chen J, Kwon CH, Parada LF. Neural and Cancer Stem Cells in Tumor Suppressor Mouse Models of Malignant Astrocytoma. Cold Spring Harb Symp Quant Biol 2008,
11. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M, et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007, 11:69-82. 10.1016/j.ccr.2006.11.020, 17222791.
12. Bao S. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760. 10.1038/nature05236, 17051156.
13. Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, Sette G, Pilozzi E, Larocca LM, Peschle C, De Maria R. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 2006, 13:1238-1241. 10.1038/sj.cdd.4401872, 16456578.
14. Goings GE, Sahni V, Szele FG. Migration patterns of subventricular zone cells in adult mice change after cerebral cortex injury. Brain Res 2004, 996:213-226. 10.1016/j.brainres.2003.10.034, 14697499.
15. Barker FG, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB. Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 1998, 42:709-720. discussion 720-703, 10.1097/00006123-199804000-00013, 9574634.
16. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111. 10.1038/35102167, 11689955.
17. Chera BS, Amdur RJ, Patel P, Mendenhall WM. A radiation oncologist's guide to contouring the hippocampus. Am J Clin Oncol 2009, 32:20-22. 10.1097/COC.0b013e318178e4e8, 19194118.
18. Barani IJ, Cuttino LW, Benedict SH, Todor D, Bump EA, Wu Y, Chung TD, Broaddus WC, Lin PS. Neural stem cell-preserving external-beam radiotherapy of central nervous system malignancies. Int J Radiat Oncol Biol Phys 2007, 68:978-985.
19. Kaplan E, P M. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958, 54:457-481.
20. Cox D. Regression models and life table. J Royal Stat Soc B 1972, 34:187-220.
21. Yang X, Darling JL, McMillan TJ, Peacock JH, Steel GG. Heterogeneity of radiosensitivity in a human glioma cell line. Int J Radiat Oncol Biol Phys 1992, 22:103-108.
22. Brandes AA, Tosoni A, Franceschi E, Sotti G, Frezza G, Amista P, Morandi L, Spagnolli F, Ermani M. Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status. J Clin Oncol 2009, 27:1275-1279. 10.1200/JCO.2008.19.4969, 19188675.
23. Tuettenberg J, Grobholz R, Seiz M, Brockmann MA, Lohr F, Wenz F, Vajkoczy P. Recurrence pattern in glioblastoma multiforme patients treated with anti-angiogenic chemotherapy. J Cancer Res Clin Oncol 2009,
24. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR, Sansom OJ, Clevers H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457:608-611. 10.1038/nature07602, 19092804.
25. Perez-Caro M, Cobaleda C, Gonzalez-Herrero I, Vicente-Duenas C, Bermejo-Rodriguez C, Sanchez-Beato M, Orfao A, Pintado B, Flores T, Sanchez-Martin M, et al. Cancer induction by restriction of oncogene expression to the stem cell compartment. Embo J 2009, 28:8-20. 10.1038/emboj.2008.253, 2600654, 19037256.
26. Alcantara Llaguno S, Chen J, Kwon CH, Jackson EL, Li Y, Burns DK, Alvarez-Buylla A, Parada LF. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 2009, 15:45-56. 10.1016/j.ccr.2008.12.006, 2650425, 19111880.
27. Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ, Bayazitov IT, Poppleton H, Zakharenko S, Ellison DW, Gilbertson RJ. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 2009, 457:603-607. 10.1038/nature07589, 2633030, 19092805.
28. Kakita A, Zerlin M, Takahashi H, Goldman JE. Some glial progenitors in the neonatal subventricular zone migrate through the corpus callosum to the contralateral cerebral hemisphere. J Comp Neurol 2003, 458:381-388. 10.1002/cne.10597, 12619072.
29. Laperriere N, Zuraw L, Cairncross G. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 2002, 64:259-273. 10.1016/S0167-8140(02)00078-6, 12242114.
30. Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006, 98:1777-1785. 10.1093/jnci/djj495, 17179479.
31. Short SC, Mitchell SA, Boulton P, Woodcock M, Joiner MC. The response of human glioma cell lines to low-dose radiation exposure. Int J Radiat Biol 1999, 75:1341-1348. 10.1080/095530099139214, 10597908.
32. Beauchesne PD, Bertrand S, Branche R, Linke SP, Revel R, Dore JF, Pedeux RM. Human malignant glioma cell lines are sensitive to low radiation doses. Int J Cancer 2003, 105:33-40. 10.1002/ijc.11033, 12672027.